[Pneumonitis caused by sirolimus: improvement after switching to everolimus].
Calle
L
L
Tejada
C
C
Lancho
C
C
Mazuecos
A
A
D000068338:Everolimus; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D008875:Middle Aged; D011014:Pneumonia / Q000150:complications*; D012074:Remission Induction; D020123:Sirolimus / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*
D007166:Immunosuppressive Agents; D000068338:Everolimus; D020123:Sirolimus